FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3035648487> ?p ?o ?g. }

• W3035648487 endingPage "e9163" @default.
• W3035648487 startingPage "e9163" @default.
• W3035648487 abstract "P-glycoprotein (P-gp) is one of the highly expressed cancer cell efflux transporters that cause the failure of chemotherapy. To reverse P-gp induced multidrug resistance, we employed a flaxseed-derived lignan; secoisolariciresinol (SECO) that acts as an inhibitor of breast cancer resistance protein; another efflux transporter that shares some substrate/inhibitor specificity with P-gp. Molecular dynamics (MD) simulation identified SECO as a possible P-gp inhibitor. Comparing root mean square deviation (RMSD) of P-gp bound with SECO with that bound to its standard inhibitor verapamil showed that fluctuations in RMSD were lower in P-gp bound to SECO demonstrating higher stability of the complex of P-gp with SECO. In addition, the superimposition of P-gp structures after MD simulation showed that the nucleotide-binding domains of P-gp bound to SECO undertook a more central closer position compared with that bound to verapamil. Using rhodamine efflux assay on NCI/ADR-RES cancer cells, SECO was confirmed as a P-gp inhibitor, where cells treated with 25 or 50 µM of SECO showed significantly higher fluorescence intensity compared to control. Using MTT assay, SECO alone showed dose-dependent cytotoxicity, where 25 or 50 µM of SECO caused significantly less NCI/ADR-RES cellular viability compared to control. Furthermore, when 50 µM of SECO was added to doxorubicin (DOX), an anticancer drug, SECO significantly enhanced DOX-induced cytotoxicity compared to DOX alone. The combination index calculated by CompuSyn software indicated synergism between DOX and SECO. Our results suggest SECO as a novel P-gp inhibitor that can re-sensitize cancer cells during DOX chemotherapy." @default.
• W3035648487 created "2020-06-19" @default.
• W3035648487 creator A5011098931 @default.
• W3035648487 creator A5024041795 @default.
• W3035648487 creator A5043847017 @default.
• W3035648487 creator A5061137778 @default.
• W3035648487 creator A5085320315 @default.
• W3035648487 date "2020-06-10" @default.
• W3035648487 modified "2023-09-26" @default.
• W3035648487 title "In silico and in vitro identification of secoisolariciresinol as a re-sensitizer of P-glycoprotein-dependent doxorubicin-resistance NCI/ADR-RES cancer cells" @default.
• W3035648487 cites W103473708 @default.
• W3035648487 cites W1983518163 @default.
• W3035648487 cites W1994265289 @default.
• W3035648487 cites W1994348363 @default.
• W3035648487 cites W2011339029 @default.
• W3035648487 cites W2019346113 @default.
• W3035648487 cites W2027439716 @default.
• W3035648487 cites W2032373538 @default.
• W3035648487 cites W2041246967 @default.
• W3035648487 cites W2050912869 @default.
• W3035648487 cites W2084777758 @default.
• W3035648487 cites W2084979694 @default.
• W3035648487 cites W2093348278 @default.
• W3035648487 cites W2102553356 @default.
• W3035648487 cites W2127247883 @default.
• W3035648487 cites W2131299583 @default.
• W3035648487 cites W2143325677 @default.
• W3035648487 cites W2151209811 @default.
• W3035648487 cites W2199386068 @default.
• W3035648487 cites W2234080940 @default.
• W3035648487 cites W2291282149 @default.
• W3035648487 cites W2294517629 @default.
• W3035648487 cites W2325213441 @default.
• W3035648487 cites W2345028093 @default.
• W3035648487 cites W2397510889 @default.
• W3035648487 cites W2422969983 @default.
• W3035648487 cites W2539460099 @default.
• W3035648487 cites W2556871197 @default.
• W3035648487 cites W2584960907 @default.
• W3035648487 cites W2593638292 @default.
• W3035648487 cites W2754354674 @default.
• W3035648487 cites W2766922062 @default.
• W3035648487 cites W2767410966 @default.
• W3035648487 cites W2775750277 @default.
• W3035648487 cites W2779716292 @default.
• W3035648487 cites W2781478615 @default.
• W3035648487 cites W2782119129 @default.
• W3035648487 cites W2782551600 @default.
• W3035648487 cites W2785010403 @default.
• W3035648487 cites W2790924287 @default.
• W3035648487 cites W2794101282 @default.
• W3035648487 cites W2802704915 @default.
• W3035648487 cites W2803123961 @default.
• W3035648487 cites W2806226961 @default.
• W3035648487 cites W2885738414 @default.
• W3035648487 doi "https://doi.org/10.7717/peerj.9163" @default.
• W3035648487 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7293189" @default.
• W3035648487 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32566390" @default.
• W3035648487 hasPublicationYear "2020" @default.
• W3035648487 type Work @default.
• W3035648487 sameAs 3035648487 @default.
• W3035648487 citedByCount "12" @default.
• W3035648487 countsByYear W30356484872020 @default.
• W3035648487 countsByYear W30356484872021 @default.
• W3035648487 countsByYear W30356484872022 @default.
• W3035648487 countsByYear W30356484872023 @default.
• W3035648487 crossrefType "journal-article" @default.
• W3035648487 hasAuthorship W3035648487A5011098931 @default.
• W3035648487 hasAuthorship W3035648487A5024041795 @default.
• W3035648487 hasAuthorship W3035648487A5043847017 @default.
• W3035648487 hasAuthorship W3035648487A5061137778 @default.
• W3035648487 hasAuthorship W3035648487A5085320315 @default.
• W3035648487 hasBestOaLocation W30356484871 @default.
• W3035648487 hasConcept C104317684 @default.
• W3035648487 hasConcept C109316439 @default.
• W3035648487 hasConcept C121608353 @default.
• W3035648487 hasConcept C133936738 @default.
• W3035648487 hasConcept C149011108 @default.
• W3035648487 hasConcept C185592680 @default.
• W3035648487 hasConcept C200082930 @default.
• W3035648487 hasConcept C202751555 @default.
• W3035648487 hasConcept C2776694085 @default.
• W3035648487 hasConcept C2778707650 @default.
• W3035648487 hasConcept C2780783641 @default.
• W3035648487 hasConcept C2781303535 @default.
• W3035648487 hasConcept C44312359 @default.
• W3035648487 hasConcept C501593827 @default.
• W3035648487 hasConcept C54355233 @default.
• W3035648487 hasConcept C55493867 @default.
• W3035648487 hasConcept C86803240 @default.
• W3035648487 hasConcept C96232424 @default.
• W3035648487 hasConcept C98274493 @default.
• W3035648487 hasConceptScore W3035648487C104317684 @default.
• W3035648487 hasConceptScore W3035648487C109316439 @default.
• W3035648487 hasConceptScore W3035648487C121608353 @default.
• W3035648487 hasConceptScore W3035648487C133936738 @default.
• W3035648487 hasConceptScore W3035648487C149011108 @default.
• W3035648487 hasConceptScore W3035648487C185592680 @default.

• next